Results 61 to 70 of about 31,575,899 (247)
Integrating Palliative Care into the Health System in Lebanon [PDF]
K2P Policy Briefs bring together global research evidence, local evidence and context-specific knowledge to inform deliberations about health policies and programmes.
Souiedan, Sara +2 more
core
In an era in which evidence is being disregarded, scientists need to speak up in support of the pursuit for truth.
Eve Marder
doaj +1 more source
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers +19 more
wiley +1 more source
Strengthening Emergency Medical Services in Lebanon [PDF]
K2P Policy Briefs bring together global research evidence, local evidence and context-specific knowledge to inform deliberations about health policies and programmes.
El Sayed, Mazen +4 more
core
When assessing the importance of materials (or other components) to a given set of applications, machine analysis of a very large corpus of scientific abstracts can provide an analyst a base of insights to develop further.
Nikhil Kalathil +4 more
doaj +1 more source
Advancing Stroke Clinical Trials Using Community Engagement and Implementation Science Approaches
ABSTRACT Stroke clinical trials are essential for advancing stroke care but can face challenges with recruitment, retention, clinical relevance, and translation into real‐world practice. We propose that integrating community engagement and implementation science approaches into stroke trials can help address these needs.
Lesli E. Skolarus +2 more
wiley +1 more source
Founding Editorial: Neuro‐Drug Discovery
Neuro-Drug Discovery, EarlyView.
Wenbin Li
wiley +1 more source
Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova +9 more
wiley +1 more source
Defence science and innovation: an affordable strategic advantage [PDF]
Overview: Australia’s neighbours in the Asia–Pacific are building high-quality science, technology, engineering and mathematics research capacities and infrastructure. As a consequence, Australia’s technological advantage in the defence domain is eroding.
Martin Callinan, Alan Gray
core
Five suggestions for substantial NIH reforms
The National Institutes of Health needs to make radical changes to ensure that biomedical research continues to thrive in the United States.
Michael Rosbash
doaj +1 more source

